Resmed Announces Participation in the Bank of America Global Healthcare Conference 2025
ResMed (NYSE: RMD) announced its participation in the upcoming Bank of America Global Healthcare Conference 2025 in London.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Summary
ResMed (NYSE: RMD) announced its participation in the upcoming Bank of America Global Healthcare Conference 2025 in London. Mick Farrell, chairman and CEO, and Dr. Carlos Nunez, chief medical officer, will present on September 23, 2025 at 1:20 p.m. BST.
The presentation will be available via audio-only webcast on the company's investor relations website, with replay access available for 30 days following the event.
Details
News Market Reaction – RMD
On Sep 17, the first trading day after this news, RMD closed 0.33% below the previous close.
Data tracked by StockTitan Argus for the Sep 17 session.
AI-generated analysis. How Rhea-AI works. Not financial advice.
SAN DIEGO, Sept. 16, 2025 (GLOBE NEWSWIRE) -- Resmed (NYSE: RMD, ASX: RMD) today announced Mick Farrell, chairman and chief executive officer, and Dr. Carlos Nunez, chief medical officer, will present at the Bank of America Global Healthcare Conference 2025 on Tuesday, September 23, 2025, beginning at approximately 1:20 p.m. (British Summer Time) in London.
More information about this event, including access to the live, audio-only webcast, may be accessed by visiting https://investor.resmed.com. The audio-only webcast replay will be available approximately 24 hours after the live webcast ends and will be accessible for the following thirty (30) days.
About Resmed
Resmed (NYSE: RMD, ASX: RMD) creates life-changing health technologies that people love. We’re relentlessly committed to pioneering innovative technology to empower millions of people in 140 countries to live happier, healthier lives. Our AI-powered digital health solutions, cloud-connected devices and intelligent software make home healthcare more personalized, accessible and effective. Ultimately, Resmed envisions a world where every person can achieve their full potential through better sleep and breathing, with care delivered in their own home. Learn more about how we’re redefining sleep health at Resmed.com and follow @Resmed.
| For investors +1 858.221.3304 investorrelations@Resmed.com | For media +1 619.510.1281 news@Resmed.com | |
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.